ArticleArchives of dermatological research2023

Dipeptidyl-peptidase IV inhibitor (DPP4i) confers increased odds of bullous pemphigoid even years after drug initiation.

Khalaf Kridin et al.PubMed ↗Publisher ↗

No numbers read from the abstract.